Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）
Clinical trial NCT07278674 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07278674
- Sponsor
- Shanghai Children's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-08
- Primary completion
- 2029-10-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.